![Jung-Min Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 7 M $ as of 2026-05-30
Jung-Min Lee currently works at Imbiologics Corp., as Director, CTO, Head-R&D Center from 2021.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMBIOLOGICS CORP. 2.03% | 2026-06-09 | 300,000 ( 2.03% ) | 6 M $ | 2026-05-30 |
| 2026-01-01 | 192,517 ( 0.83% ) | 733 276 $ | 2026-05-30 | |
Amicogen, Inc.
 Amicogen, Inc. BiotechnologyHealth Technology Develops and markets enzyme products and functional food materials 0.02% | 2024-11-28 | 11,890 ( 0.02% ) | 12 426 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| IMBIOLOGICS CORP. | Chief Tech/Sci/R&D Officer | 2021-01-12 |
Active
Inactive
Listed companies
Private companies
| Private companies | 1 |
|---|---|
Imbiologics Corp.
 Imbiologics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops antibodies for autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
